
Oxford Biomedica
Pioneering gene and cell therapy with innovative viral vector solutions for pharmaceutical and biotech companies.
Enterprise value
$506m
Share price
£3.16 OXB.L
Company register number
Recent deals
Authorizing premium user...
Pioneering gene and cell therapy with innovative viral vector solutions for pharmaceutical and biotech companies.